Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Colucci

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
DICP : the Annals of Pharmacotherapy|October 1, 1991
Monitoring serum digoxin concentrations during digoxin immune Fab therapyM R Ujhelyi, R D Colucci, D M Cummings, et al.
Annals of Internal Medicine|August 15, 1993
Influence of digoxin immune Fab therapy and renal dysfunction on the disposition of total and free digoxinM R Ujhelyi, S Robert, D M Cummings, et al.
Clinical Pharmacology and Therapeutics|October 1, 1993
Disposition of digoxin immune Fab in patients with kidney failureM R Ujhelyi, S Robert, D M Cummings, et al.
Clinical Pharmacology and Therapeutics|November 1, 1995
Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptiveV Saano, P Glue, C R Banfield, et al.
Clinical Pharmacology and Therapeutics|September 1, 1995
Effects of felbamate on the pharmacokinetics of phenobarbitalP Reidenberg, P Glue, C R Banfield, et al.
Clinical Pharmacology and Therapeutics|October 1, 1995
Effects of felbamate on the pharmacokinetics of the monohydroxy and dihydroxy metabolites of oxcarbazepineJ A Hulsman, T W Rentmeester, C R Banfield, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
DICP : the Annals of Pharmacotherapy|October 1, 1991
Monitoring serum digoxin concentrations during digoxin immune Fab therapyM R Ujhelyi, R D Colucci, D M Cummings, et al.
Annals of Internal Medicine|August 15, 1993
Influence of digoxin immune Fab therapy and renal dysfunction on the disposition of total and free digoxinM R Ujhelyi, S Robert, D M Cummings, et al.
Clinical Pharmacology and Therapeutics|October 1, 1993
Disposition of digoxin immune Fab in patients with kidney failureM R Ujhelyi, S Robert, D M Cummings, et al.
Clinical Pharmacology and Therapeutics|November 1, 1995
Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptiveV Saano, P Glue, C R Banfield, et al.
Clinical Pharmacology and Therapeutics|September 1, 1995
Effects of felbamate on the pharmacokinetics of phenobarbitalP Reidenberg, P Glue, C R Banfield, et al.
Clinical Pharmacology and Therapeutics|October 1, 1995
Effects of felbamate on the pharmacokinetics of the monohydroxy and dihydroxy metabolites of oxcarbazepineJ A Hulsman, T W Rentmeester, C R Banfield, et al.
Pageof 3